Sylke Maas

Health Technology

Profile

Sylke Maas is a former Global Director-Brand at Novartis Pharma AG, former Head-Business Unit Oncology at Hexal AG, former Head-Commercial Operations Management Emerging at Sandoz International GmbH, former VP-Investor Relations & Business Strategy at BioNTech SE, and former Partner at Interpharmalink.

Former positions of Sylke Maas

Companies	Position	End
Hexal AG Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany.	Corporate Officer/Principal	-
Sandoz International GmbH Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria.	Corporate Officer/Principal	-
Interpharmalink	Corporate Officer/Principal	-
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.	Corporate Officer/Principal	-
BIONTECH SE	Investor Relations Contact	-

See the detail of Sylke Maas's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies